Tian-Wei Fu

Zhejiang Provincial People's Hospital

Papers

2

Total Citations

11

H-Index

2

About

Dr. Tian-Wei Fu is a leading hepatobiliary surgeon and researcher whose work focuses on advancing minimally invasive surgical techniques for liver cancer, particularly hepatocellular carcinoma (HCC). His major contributions center on comparing the safety and efficacy of laparoscopic versus robotic complex hepatectomy, a high-stakes procedure for solitary HCC. Through rigorous multicenter propensity score-matched analyses, Dr. Fu has provided critical evidence that robotic surgery may offer comparable or superior perioperative outcomes, including reduced morbidity, when performed by experienced teams. His landmark 2024 study on this topic has already garnered over 11 citations, reflecting its immediate impact on clinical decision-making and surgical practice. By systematically evaluating these advanced approaches, Dr. Fu helps define best practices for complex liver resections, directly influencing how surgeons select techniques to optimize patient recovery. His work is essential reading for trainees and specialists in hepatobiliary surgery, offering data-driven insights that balance innovation with patient safety.

Research Focus

Key Achievements

2
H-Index
2
Papers
11
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Multicenter propensity score-matched analysis to compare perioperative morbidity after laparoscopic or robotic complex hepatectomy for solitary hepatocellular carcinoma
9 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: Zhejiang Provincial People's Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago